AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,000 | -96.1% | 24,153 | -89.4% | 0.00% | – |
| Q2 2021 | $305,000 | +317.8% | 228,806 | +558.4% | 0.00% | – |
| Q1 2021 | $73,000 | +46.0% | 34,751 | +99.8% | 0.00% | – |
| Q4 2020 | $50,000 | -19.4% | 17,394 | -14.9% | 0.00% | – |
| Q3 2020 | $62,000 | -47.5% | 20,433 | -67.8% | 0.00% | – |
| Q1 2020 | $118,000 | +247.1% | 63,379 | +381.4% | 0.00% | – |
| Q1 2018 | $34,000 | -77.2% | 13,166 | -76.1% | 0.00% | – |
| Q4 2017 | $149,000 | -51.8% | 55,105 | -33.0% | 0.00% | – |
| Q2 2017 | $309,000 | -23.7% | 82,272 | +74.4% | 0.00% | – |
| Q2 2015 | $405,000 | -32.2% | 47,180 | -26.7% | 0.00% | – |
| Q1 2015 | $597,000 | +71.6% | 64,352 | +13.6% | 0.00% | – |
| Q4 2014 | $348,000 | -43.1% | 56,641 | -32.4% | 0.00% | – |
| Q3 2014 | $612,000 | +215.5% | 83,824 | +277.0% | 0.00% | – |
| Q2 2014 | $194,000 | – | 22,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |